Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 January 2018 Photo Charl Devenish
Researcher tackling drug-resistant TB through molecular methods
Dr Anneke van der Spoel van Dijk is invested in contributing to the global effort of stopping TB by 2035.

The work of Dr Anneke van der Spoel van Dijk investigates the spread of TB in the Free State population using techniques such as next generation sequencing, spoligotyping and MIRU-VNTR typing. Dr Van der Spoel van Dijk, a senior medical scientist in the Department of Medical Microbiology at the University of the Free State (UFS) also looks at drug resistance in her research. This work informs decisions about how best to treat patients with multidrug-resistant TB (MDR-TB). 

She employs rapid molecular techniques to track one of Africa’s most serious diseases, tuberculosis (TB). 

Drug resistance
Scientists assist the National Health Laboratory Service and Department of Health in trying to refine the diagnostic tools to identify these cases earlier. Dr Van der Spoel van Dijk explains: “Until recently, it took up to two years to fine-tune treatment decisions for patients with MDR-TB. Patients get a cocktail of anti-TB drugs, but it takes time to find the right combination. Re-infection and relapse (patients stopping treatment for several reasons) add to the diagnostic and treatment management challenges.

Enormous impact
“Now doctors can reduce the time needed for diagnostic certainty to about seven days, while new drugs allow reduction of treatment from more than 18 to nine months. This can have an enormous impact on the life of many patients.”

Dr Van der Spoel van Dijk’s work forms part of research in the faculty looking at resistance development in TB strains. She is currently also doing her doctoral thesis on the differences and incidence of MDR-TB among adolescents versus adults. Dr Van der Spoel van Dijk says: “It is a complicated picture, but we hope to unravel it to support better diagnostic tools and patient care.”

As part of the National Health Laboratory Service, her department is playing an important role in TB diagnostics and the training of scientists and future pathologists. “Our work is contributing to the global vision to stop TB by 2035,” Dr Van der Spoel van Dijk says.

News Archive

Miss South Africa is a Kovsie
2014-04-01

 

Twenty-one-year-old Rolene Strauss, a third-year medical student at the University of the Free State (UFS), was crowned as Miss South Africa at a gala event at Sun City the weekend. Rolene was also the favourite on Twitter.

Another Kovsie, Dipalesa Mbolo, honours student in Business Management at the UFS, was also one of the finalists in the Miss South Africa pageant.

In her acceptance speech, Rolene said that she dearly loves South Africa. “This is where I can live, speak, learn and love freely. This is where my dreams come true. I am very proud of our country and shall always have a purpose here,” Rolene said.

Rolene said that Prof Jonathan Jansen, the Vice-Chancellor and Rector of the UFS, is an inspiration to her. “He stands up for what he believes in and enjoys what he is doing. He wants the best for his students and supports them in everything they do,” she said.

The university community is very proud of Rolene, and it is confirmed by Prof Jansen. “I am extremely proud of Rolene Strauss, for she has proved that physical beauty, academic excellence and public duty can come together in one person, and offer a powerful platform for transforming communities in need that would otherwise remain invisible, were it not for such a wonderful young role model,” he said.

On the year which lies ahead, Rolene said: “It will be a year during which I shall give back, say thank you and be a good example of the potential that especially women and South Africans may have in our country.”

 

 

 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept